Li X et al. |
20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616. |
2014 |
PLoS ONE |
pmid:24763529
|
Tse MM et al. |
Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. |
2013 May-Jun |
Vascul. Pharmacol. |
pmid:23466634
|
Eid S et al. |
Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. |
2013 Jul-Sep |
J. Biol. Regul. Homeost. Agents |
pmid:24152838
|
Imig JD |
Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23333581
|
Tunctan B et al. |
NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:22975359
|
Tunctan B et al. |
5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23454652
|
Ge Y et al. |
Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23500064
|
Toth P et al. |
Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats. |
2013 |
Br. J. Pharmacol. |
pmid:23194285
|
Eid S et al. |
20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway. |
2013 |
PLoS ONE |
pmid:23936373
|
Ding Y et al. |
20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension. |
2013 |
Am. J. Physiol. Renal Physiol. |
pmid:23825080
|
Lukaszewicz KM et al. |
Introgression of Brown Norway CYP4A genes on to the Dahl salt-sensitive background restores vascular function in SS-5(BN) consomic rats. |
2013 |
Clin. Sci. |
pmid:22938512
|
Schuck RN et al. |
Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. |
2013 |
Atherosclerosis |
pmid:23466098
|
Anwar-Mohamed A et al. |
Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice. |
2013 |
Xenobiotica |
pmid:23409951
|
Lukaszewicz KM and Lombard JH |
Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat. |
2013 |
Clin. Sci. |
pmid:23438293
|
Filosa JA and Iddings JA |
Astrocyte regulation of cerebral vascular tone. |
2013 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:23792684
|
Edson KZ and Rettie AE |
CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities. |
2013 |
Curr Top Med Chem |
pmid:23688133
|
Alsaad AM et al. |
Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. |
2013 |
Drug Metab. Rev. |
pmid:23600686
|
Wu CC et al. |
Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. |
2013 |
J. Am. Soc. Nephrol. |
pmid:23641057
|
Orozco LD et al. |
20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries. |
2013 |
J. Pharmacol. Exp. Ther. |
pmid:23658377
|
Ngo AT et al. |
Significance of K(ATP) channels, L-type Ca²⺠channels and CYP450-4A enzymes in oxygen sensing in mouse cremaster muscle arterioles in vivo. |
2013 |
BMC Physiol. |
pmid:23663730
|
Li H and Zhu Y |
[Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium]. |
2013 |
Sheng Li Ke Xue Jin Zhan |
pmid:23671992
|
Li Y et al. |
Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. |
2013 |
Toxicol. Appl. Pharmacol. |
pmid:23747687
|
Kim DH et al. |
Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes. |
2013 |
J. Lipid Res. |
pmid:23293373
|
Lima R et al. |
Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats. |
2013 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:23220478
|
Fordsmann JC et al. |
Increased 20-HETE synthesis explains reduced cerebral blood flow but not impaired neurovascular coupling after cortical spreading depression in rat cerebral cortex. |
2013 |
J. Neurosci. |
pmid:23392684
|
Issan Y et al. |
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. |
2013 |
Prostaglandins Other Lipid Mediat. |
pmid:23291334
|
Jiang H et al. |
Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. |
2013 |
Am. J. Hypertens. |
pmid:23382413
|
Hadfield J et al. |
Modeling secondary messenger pathways in neurovascular coupling. |
2013 |
Bull. Math. Biol. |
pmid:23358799
|
Wu J et al. |
Synergistical effect of 20-HETE and high salt on NKCC2 protein and blood pressure via ubiquitin-proteasome pathway. |
2013 |
Hum. Genet. |
pmid:23104236
|
Han Y et al. |
20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production. |
2013 |
Circ. J. |
pmid:23585488
|
Kunduri SS et al. |
Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. |
2013 |
J. Cardiovasc. Pharmacol. |
pmid:23519140
|
Elshenawy OH et al. |
20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. |
2013 |
Curr. Drug Metab. |
pmid:23701160
|
Ma F et al. |
Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney. |
2013 |
Mol. Pharmacol. |
pmid:23729436
|
Toth P et al. |
Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. |
2013 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:24097425
|
Bubb KJ et al. |
Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase A. |
2013 |
Hypertension |
pmid:23753406
|
Fan F et al. |
20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels. |
2013 |
PLoS ONE |
pmid:24324797
|
Van Bogaert I et al. |
Preparation of 20-HETE using multifunctional enzyme type 2-negative Starmerella bombicola. |
2013 |
J. Lipid Res. |
pmid:23966667
|
Toth P et al. |
Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. |
2013 |
J. Cereb. Blood Flow Metab. |
pmid:23942363
|
Alexanian A et al. |
20-HETE-producing enzymes are up-regulated in human cancers. |
2012 Jul-Aug |
Cancer Genomics Proteomics |
pmid:22798501
|
Singh TU et al. |
Arachidonic acid inhibits Naâº-Kâº-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery. |
2012 Jan-Feb |
Vascul. Pharmacol. |
pmid:22155164
|
Theken KN et al. |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. |
2012 |
Atherosclerosis |
pmid:22503544
|
Renic M et al. |
Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures. |
2012 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:22245774
|
Yang ZJ et al. |
Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor. |
2012 |
J. Neurochem. |
pmid:22251169
|
Lai G et al. |
20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway. |
2012 |
Mol. Endocrinol. |
pmid:22918876
|
Chen L et al. |
20-HETE in neovascularization. |
2012 |
Prostaglandins Other Lipid Mediat. |
pmid:22227460
|
Cheng J et al. |
Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22723444
|
Tian T et al. |
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on adriamycin-induced toxicity of human renal tubular epithelial cell (HK-2). |
2012 |
Eur. J. Pharmacol. |
pmid:22421401
|
Nikolaeva S et al. |
The circadian clock modulates renal sodium handling. |
2012 |
J. Am. Soc. Nephrol. |
pmid:22440902
|
Williams JM et al. |
Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats. |
2012 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:22442195
|
Tunctan B et al. |
A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid. |
2012 |
Antiinflamm Antiallergy Agents Med Chem |
pmid:23013331
|